[{"Assets_0_Q3_USD":263795000.0,"CommonStockSharesOutstanding_0_Q3_shares":46673977.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-78059000.0,"NetIncomeLoss_1_Q3_USD":-32842000.0,"NetIncomeLoss_3_Q3_USD":-77762000.0,"StockholdersEquity_0_Q3_USD":211894000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44517134.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":41314044.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]